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Systems Analysis of the Liver 
Transcriptome in Adult Male 
Zebrafish Exposed to the Plasticizer 
(2-Ethylhexyl) Phthalate (DEHP)
Matthew Huff1,2, Willian A. da Silveira1,3, Oliana Carnevali4, Ludivine Renaud5 & 
 Gary Hardiman1,5,6,7,8
The organic compound diethylhexyl phthalate (DEHP) represents a high production volume chemical 
found in cosmetics, personal care products, laundry detergents, and household items. DEHP, along with 
other phthalates causes endocrine disruption in males. Exposure to endocrine disrupting chemicals has 
been linked to the development of several adverse health outcomes with apical end points including 
Non-Alcoholic Fatty Liver Disease (NAFLD). This study examined the adult male zebrafish (Danio 
rerio) transcriptome after exposure to environmental levels of DEHP and 17α-ethinylestradiol (EE2) 
using both DNA microarray and RNA-sequencing technologies. Our results show that exposure to 
DEHP is associated with differentially expressed (DE) transcripts associated with the disruption of 
metabolic processes in the liver, including perturbation of five biological pathways: ‘FOXA2 and FOXA3 
transcription factor networks’, ‘Metabolic pathways’, ‘metabolism of amino acids and derivatives’, 
‘metabolism of lipids and lipoproteins’, and ‘fatty acid, triacylglycerol, and ketone body metabolism’. 
DE transcripts unique to DEHP exposure, not observed with EE2 (i.e. non-estrogenic effects) 
exhibited a signature related to the regulation of transcription and translation, and ruffle assembly 
and organization. Collectively our results indicate that exposure to low DEHP levels modulates the 
expression of liver genes related to fatty acid metabolism and the development of NAFLD.
Endocrine Disrupting Compounds (EDCs) are ubiquitous chemical compounds used in numerous consumer 
products as plasticizers or flame retardants that have been shown to have unforeseen impacts on the ecosystem1 
and human health2. As their chemical structures are similar to the structures of natural hormones3, EDCS are able 
to bind and activate many receptors, including nuclear hormone receptors4,5, and disrupt the endocrine system6. 
In light of these recent studies, EDCs are now considered chemicals of emerging concern7, and it is critical to fully 
understand the impact they might have on the health of the ecosystem and mankind at environmental levels.
A specific subset of EDCs, the xenoestrogens (XEs), are able to mimic 17β-estradiol, a natural female 
estrogen8. The effects of these XEs on specific cell types, including prostate, fibroblast, and neural cells, have 
recently been characterized9,10. However, their impact on the liver, the main site of detoxification and metabo-
lism of xenobiotics11, has not been as well defined. Commonly used as a plasticizer of polyvinyl chloride (PVC), 
di(2-ethylhexyl) phthalate (DEHP), a XE gives PVC flexibility, strength and bendability, and is currently the only 
phthalate used in PVC medical devices12,13; the most highly DEHP exposed patients are neonates in the neonatal 
intensive care unit14. It is also present in office supplies and dust15 (notebooks, report covers and sheet protectors) 
and children’s toys16.
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Two recent studies suggested that DEHP may cause lipid accumulation and nonalcoholic fatty liver disease 
(NAFLD) by promoting PPARα and sterol regulator element-binding protein 1c (SREBP-1c) expression17,18. 
Furthermore, exposure to DEHP has been found to disrupt the insulin signaling pathway in rats and the human 
L-02 cell line through activation of PPARγ4, reducing the ability of the liver to maintain glucose homeostasis, 
leading to insulin resistance.
In this study, we examined the effect of exposure to 5.8 nM of DEHP on the liver transcriptome, a concentra-
tion that is relevant to observed environmental levels19. In the United States, concentrations of DEHP in wastewa-
ter derived from Oakland, CA ranged from 2.53 to 6913.2 nM20. Studies in model organisms indicated that DEHP 
exposures ranging from 0.01 to 25.6 nM are sufficient to negatively affect animal growth and reproduction21,22.
To examine the effects of DEHP exposure on the adult male hepatic transcriptome, we exploited the zebraf-
ish model (Danio rerio) and undertook a systems level analysis. We performed microarray and RNA sequenc-
ing analyses, and considered the data in the context of the recently described Adverse Outcomes Framework 
(AOF)23. This approach defines an adverse outcome as the end result of a causal series of events punctuated by 
“key events” (KE), the results of a molecular initiating event (MIE), a molecular interaction between a chemical 
stressor and a target biomolecule that alters gene expression. In parallel we assessed the effect of the E2 analogue 
17α-ethinylestradiol (EE2) with the objective of deciphering the estrogenic and non-estrogenic effects of DEHP. 
This study is the first to use deep transcriptome profiling to explore the effects of exposure to DEHP on the zebraf-
ish liver.
Results
Molecular changes in DEHP exposed livers revealed altered translational regulation. To exam-
ine the effect of 21-day exposure to DEHP (5.8 nM) or EE2 (0.65 nM) on the liver of adult male zebrafish, we 
carried out a microarray experiment and analyzed the transcriptome of exposed and control fish. Unique array 
probes were ranked using an interest statistic described previously, which reflects the understanding that the 
gene with a greater absolute fold change is potentially more interesting24–26. Of the top 3,000 ranked DE tran-
scripts, 1,454 mRNAs were shared amongst the EE2 and DEHP exposures. EE2 and DEHP exposures altered 
the expression of 1,090 and 1,072 unique mRNAs respectively (Fig. 1A). Next, we analyzed the top ranked 3,000 
DE transcripts using the Gene Ontology (GO) enrichment analysis and visualization tool (GOrilla)27. DEHP 
exposure enriched a number of carbohydrate metabolism processes, including chitin metabolic and chitin cata-
bolic processes (q = 4.46E-05 and 8.91E-05 respectively), amino sugar catabolic process (q = 1.16E-04) and ion 
transport (q = 3.63E-02) (Table 1, DEHP Total and Fig. 1B). Exposure to EE2 (Table 1, EE2 Total) was associated 
with enrichment in biological processes such as organic acid metabolic process (q = 9.31E-03), carboxylic acid 
metabolic processes (q = 1.14E-02), and oxoacid metabolic process (q = 1.16E-02), among other terms associated 
with lipid and fatty acid metabolism (Fig. 1C). We next performed enrichment analysis using DE gene signatures 
that were unique for DEHP and observed significant enrichment in terms related to regulation of translational 
initiation (q = 1.65E-01), negative regulation of translation (q = 2.48E-01), ruffle organization (q = 1.93E-01) and 
ruffle assembly (q = 2.14E-01) (Table 1, DEHP Unique and Fig. 1D). We also performed enrichment analysis 
using DE gene signatures unique to EE2, but found no significant enrichments (data not shown).
Functional enrichment analysis of human orthologs revealed altered transcriptional and trans-
lational pathways. We mapped zebrafish genes of interest to their human orthologs using Ensembl28,29 
genes to take advantage of the more extensive functional and non-inferred electronic annotations available based 
on the human genome, as illustrated in Fig. 2 6. Using the assigned human orthologs, we performed enrich-
ment analysis with the ‘Transcriptome, ontology, phenotype, proteome, and pharmacome annotations’ based 
gene list functional enrichment analysis (ToppFun) tool and observed that exposure to DEHP and EE2 both 
had a significant impact on metabolism (Table 2, Supplementary Tables S1–S4), including the organonitro-
gen compound biosynthetic process (DEHP Total, q = 3.87E-16) and oxoacid metabolic process (EE2 Total, 
q = 1.03E-14). Furthermore, exposures to EE2 and DEHP were both linked with significant enrichment relating 
to apoptotic processes (DEHP Total, programmed cell death, q = 2.76E-10 and EE2 Total, apoptotic process, 
q = 1.38E-11), while DE genes unique to DEHP were associated with enrichment in cell cycle-related processes 
(DEHP Total, q = 5.23E-11). DEHP exposure resulted in a unique enrichment signature related to RNA process-
ing (DEHP Unique, q = 1.80E-04) and ribonucleoprotein complex biogenesis (DEHP Unique, q = 1.19E-03). In 
terms of co-expressed genes, we identified an overlap in the DE genes of interest to this study with genes that are 
up-regulated in the zebrafish crash & burn (crb) mutant for the bmyb gene (EE2 Total, q = 6.07E-21) and genes 
upregulated in hepatoblastoma (liver cancer cell) samples (DEHP Total, q = 2.26E-24). In DE genes expressed 
only after exposure to DEHP, we found commonality with genes up-regulated by activation of the mamma-
lian target of rapamycin complex 1 (mTORC1) pathway (Table 2, DEHP Unique q = 8.83E-06, Supplementary 
Figure S1 and Supplementary Table S5).
Using ToppFun’s pathway analysis module to examine exposure to DEHP, we identified five pathways of 
interest (Table 3 and Supplementary Table S6): FOXA2 and FOXA3 transcription factor networks (Pathway 
ID = 137911), Metabolic pathways (132956), metabolism of amino acids and derivatives (1270158), metabolism 
of lipids and lipoproteins (1270001), and fatty acid, triacylglycerol, and ketone body metabolism (1270010). Our 
data suggests that DEHP influences expression of genes associated with metabolism, in particular the metabolism 
of lipids and fatty acids.
RNA-Seq analysis identified changes in cellular response and translation. High-throughput 
RNA-Seq was carried out to further explore transcriptomic changes in response to DEHP exposure using an 
advanced analytical pipeline we have recently described30. Based on DESeq2 analysis, genes with an adjusted 
p-value of less than or equal to 0.4 were selected31–33. We found that EE2 and DEHP altered the expression of 326 
www.nature.com/scientificreports/
3SCieNtifiC RepoRTS |  (2018) 8:2118  | DOI:10.1038/s41598-018-20266-8
total genes; 66 genes were differentially expressed upon exposure to both DEHP and EE2, whereas exposures to 
EE2 and DEHP altered expression in 40 and 220 unique transcripts respectively (Fig. 3A).
Using these significant DE transcripts, we performed GOrilla analysis and found that exposures to both DEHP 
and EE2 were associated with enrichment of metabolic processes, particularly those relating to lipid metabo-
lism (Table 4 and Fig. 3B,C), including lipid biosynthetic (DEHP Total, q = 7.01E-08 and EE2 Total, q = 8.58E-
07) and metabolic processes (DEHP Total, q = 1.05E-08, EE2 Total, q = 2.58E-04) (all q-values are Bonferroni 
adjusted). Exposure to DEHP (DEHP Total, Table 4 and Fig. 3B) was associated with enrichments relating to 
translation (q = 6.09E-14), including cytoplasmic translation (q = 5.19E-04), and cellular responses to hypoxia 
(q = 1.24E-02) and response to estrogen (q = 2.94E-04). For exposure to EE2 (EE2 Total, Table 4 and Fig. 3C), 
we found unique enrichments related to the insulin signaling pathway (q = 1.03E-01) and the triglyceride meta-
bolic pathway (q = 2.05E-02); the latter is supported with enrichments in triglyceride catabolism (q = 9.03E-02) 
and triglyceride-rich lipoprotein particle remodeling (q = 6.13E-02). Analysis of only the genes associated with 
exposure to DEHP (DEHP Unique, Table 4 and Fig. 3D) returned significant enrichment relating to translation 
(q = 3.10E-16), fatty acid biosynthesis (q = 1.26E-15), and the protein metabolic processes (q = 1.29E-02). No 
significant enrichments were detected with analysis of DE genes unique to EE2.
Functional enrichment analysis of RNA-seq data projected onto human orthologs identified 
dysregulation of translational and insulin-related pathways. We performed a functional enrich-
ment analysis of the human orthologs using ToppFun and found that exposure to DEHP and EE2 is related 
to enrichment in metabolic processes (Table 5). In particular, EE2 enriched several lipid-related processes, 
including lipid biosynthesis (q = 3.87E-09) and fatty acid metabolism (q = 7.42E-08) (Table 5, EE2 Total; 
Supplementary Table S7). DEHP affected biological processes (Table 5, DEHP Total; Supplementary Table S8), 
such as co-translational protein localization to membranes (q = 1.01E-19), nuclear-transcribed mRNA catabolic 
process (q = 1.79E-16) and translational initiation (q = 2.84E-15). Analysis of genes unique to DEHP exposure 
Figure 1. Functional Analyses. (A) Overlap of the top 3,000 ranked DE expressed liver transcripts from 5.8 nM 
DEHP and 0.65 nM EE2 exposed adult male zebrafish relative to control fish as determined by microarray 
analysis. (B–D) Gene Ontology Biological Process analyses: Scatterplots shows the cluster representatives 
(i.e. terms remaining after the redundancy reduction) in a two dimensional space derived by applying 
multidimensional scaling to a matrix of the GO terms’ semantic similarities. Bubble color indicates the p-value 
(legend in upper right-hand corner); size indicates the frequency of the GO term in the underlying GOA 
database (bubbles of more general terms are larger). GO BP analysis of DE genes in (B) DEHP and (C) EE2 
exposed livers. (D) GO BP analysis of DE genes unique to DEHP (not DE in EE2 exposed).
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GO Term q-value
DEHP-Total
chitin metabolic process 4.46E-05
chitin catabolic process 8.91E-05
amino sugar catabolic process 1.16E-04
glucosamine-containing compound metabolic process 1.39E-04
glucosamine-containing compound catabolic process 1.74E-04
aminoglycan catabolic process 2.31E-04
amino sugar metabolic process 8.38E-04
aminoglycan metabolic process 3.38E-03
carbohydrate derivative catabolic process 8.12E-03
sulfur compound transport 2.82E-02
sulfate transport 3.10E-02
anion transport 3.44E-02
ion transport 3.63E-02
inorganic anion transport 5.55E-02
transmembrane transport 5.71E-02
response to vitamin B3 1.28E-01
organonitrogen compound catabolic process 1.69E-01
monovalent inorganic cation homeostasis 2.07E-01
EE2-Total
organic acid metabolic process 9.31E-03
monocarboxylic acid metabolic process 1.12E-02
carboxylic acid metabolic process 1.14E-02
oxoacid metabolic process 1.16E-02
fatty acid metabolic process 1.53E-02
long-chain fatty acid metabolic process 4.58E-02
lipid metabolic process 5.10E-02
single-organism metabolic process 5.51E-02
small molecule metabolic process 1.12E-01
unsaturated fatty acid metabolic process 1.25E-01
carboxylic acid transmembrane transport 1.30E-01
response to lipid 1.35E-01
long-chain fatty acid biosynthetic process 1.38E-01
organic acid transmembrane transport 1.39E-01
response to biotic stimulus 1.44E-01
response to external biotic stimulus 1.56E-01
epoxygenase P450 pathway 1.87E-01
monounsaturated fatty acid metabolic process 2.14E-01
response to external stimulus 2.23E-01
monounsaturated fatty acid biosynthetic process 2.26E-01
DEHP-Unique
negative regulation of cellular biosynthetic process 1.35E-01
negative regulation of gene expression 1.44E-01
negative regulation of biosynthetic process 1.62E-01
regulation of translational initiation 1.65E-01
negative regulation of cellular macromolecule biosynthetic process 1.74E-01
negative regulation of translational intitiation 1.87E-01
protein phosphorylation 1.91E-01
ruffle organization 1.93E-01
ruffle assembly 2.14E-01
negative regulation of translation 2.48E-01
negative regulation of macromolecule biosynthetic process 2.62E-01
negative regulation of cellular amide metabolic process 2.71E-01
Table 1. GOrilla functional enrichment analysis. The top 3,000 ranked DE expressed liver transcripts as 
determined by microarray analysis from 5.8 nM DEHP and 0.65 nM EE2 exposed adult male zebrafish relative 
to control fish were used to search for enriched GO: Biological Process terms. The most significant terms for the 
DEHP and EE2 exposures, and those unique to DEHP (i.e. not present in in EE2 exposed) are presented.
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supported these findings (Table 5, DEHP Unique): translation (q = 2.03E-16), processing of rRNA (q = 5.46E-14) 
and biogenesis of the ribonucleoprotein complex (q = 6.20E-11). Transcripts unique to EE2 were associated with 
enrichment in the triglyceride metabolic process (Table 5, EE2 Unique, q = 5.09E-01), response to dietary excess 
(q = 5.47E-01), and the neutral lipid metabolic process (q = 7.28E-01).
In terms of Co-Expression (Supplementary Tables S9,10), in response to DEHP exposure (Table 5, DEHP 
total; Supplementary Table S10 and Figure S1), we observed an overlap with genes up-regulated with activation of 
the mTORC1 complex (q = 6.79E-14) and genes involved in cholesterol homeostasis (q = 6.58E-12).
As the mTORC1 complex is intricately associated with the Insulin-like growth factors (IGF-I and IGF-II) sys-
tem that regulates metabolism we hypothesized that DEHP exposure could impact liver weight. In order to assess 
this functional effect we measured liver tissue weights from fish exposed to 100 nM DEHP, 100 nM EE2 or con-
trol ethanol exposure. This revealed reduction in the size of the liver in the DEHP exposed fish (Supplementary 
Figure S1). In response to EE2 exposure (Table 5; Supplementary Table S9), we observed co-expression of genes 
associated with fatty acid metabolism (q = 4.65E-04), as well as genes related to changes in expression observed 
in hepatocellular carcinoma (HCC) (q = 3.12E-05). Analysis of genes unique to exposure to DEHP (Table 5) 
identified an overlap with genes associated with the sterol regulatory element binding transcription factors 
(SREBFs) 1 and 2 and the SREBP cleavage-activating protein (SCAP) in the livers of transgenic mice (q = 4.78E-
10). We found no significant overlap associated with the genes unique to exposure to EE2 (data not shown). 
Pathway analysis of genes DE expressed by exposure to DEHP revealed five pathways of interest (Supplementary 
Table S11): FOXA2 and FOXA3 transcription factor networks, metabolic pathways, metabolism of amino acids 
and derivatives, metabolism of lipids and lipoproteins, and fatty acid, triacylglycerol, and ketone body metab-
olism. We explored the expression patterns of the genes associated with these pathways in the control and the 
DEHP-exposed fish (Fig. 4) using heatmaps which show a clear signature associated with DEHP exposure.
Discussion
Environmental chemicals can act through multiple toxicity pathways and induce adverse health outcomes. The 
relationship between a contaminant and a particular outcome in an individual is dependent on genetic back-
ground, target tissue, dose and other factors besides the mechanisms of action (MOA). Transitioning from cur-
rent risk assessment practices to approaches based on big data collection and integration requires a paradigm shift 
in how this is executed. A significant challenge to risk assessment is accurately relating chemical impacts across 
species and stratifying effects or MOAs that are likely to be detrimental to human health. One recent strategy 
is the adverse outcome (AOP) pathways framework that organizes mechanistic and/or predictive relationships 
between initial chemical–biological interactions, pathways and networks, and adverse phenotypic outcomes23.
Figure 2. Functional annotations: (A) comparison of zebrafish and human annotations. Zebrafish has larger 
number of annotated gene products relative to human, 22,171 versus 19,392 (as of April 2017). In human, non-
inferred electronic (black bar) and functional annotations (dark grey bar) are 5 times and 2 times better defined 
respectively than they are in zebrafish. In zebrafish, gene products annotated are slightly better defined than 
they are in human (light grey bar).
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The goal of this study was to assess the effect of environmental levels of DEHP on the liver transcriptome in 
the adult male zebrafish using a systems level approach. Our analyses utilized a well described whole genome 
DNA microarray coupled to GOrilla analyses and demonstrated that DEHP deregulates carbohydrate metab-
olism, including chitin and aminoglycans, and protein synthesis. ToppFun analysis of the significant DE genes 
from the microarray experiments projected onto their human homologs suggested that DE genes shared by 
both DEHP/EE2 exposures mapped to pathways related to metabolism, the cell cycle, apoptosis and response 
to external stimuli. Additionally, DE transcripts unique to DEHP exposure exhibited a signature related to the 
GO Term Bonferroni q-value
GO: Biological Process
DEHP - Total
organonitrogen compound biosynthetic process 3.87E-16
response to steroid hormone 3.91E-11
cell cycle process 5.23E-11
programmed cell death 2.76E-10
EE2 - Total
response to endogenous stimulus 7.10E-16
oxoacid metabolic process 1.03E-14
peptide metabolic process 8.23E-12
apoptotic process 1.38E-11
DEHP - Unique
cell cycle 2.00E-05
RNA processing 1.80E-04
positive regulation of transcription, DNA-templated 7.85E-04
ribonucleoprotein complex biogenesis 1.19E-03
EE2 - Unique
negative regulation of transcription from RNA 
polymerase II promoter 2.56E-04
regulation of cell differentiation 1.94E-03
negative regulation of gene expression 1.22E-02
negative regulation of cellular biosynthetic process 1.09E-01
Co-Expression
DEHP - Total
Genes whose promoters are bound by MYC 
[GeneID = 4609], according to MYC
Target Gene Database. 1.85E-24
Genes up-regulated in robust Cluster 2 (rC2) of 
hepatoblastoma samples
compared to those in the robust Cluster 1 (rC1). 2.26E-24
Genes up-regulated through activation of mTORC1 
complex. 3E-22
EE2 - Total
Human Liver_Tzur09_1908genes 7.19E-22
Human orthologs of genes up-regulated in the crb 
(‘crash and burn’) zebrafish
mutant that represents a loss-of-function mutation 
in BMYB [GeneID = 4605]. 6.07E-21
DEHP - Unique
Genes down-regulated in erythroid progenitor cells 
from fetal livers of E13.5
embryos with KLF1 [GeneID = 10661] knockout 
compared to those from the wild type embryos. 4.59E-14
Genes up-regulated through activation of mTORC1 
complex. 8.83E-06
EE2 - Unique
Mouse Liver_White05_638genes 3.21E-06
Rat Liver_Perez-Carreon06_290genes 4.21E-04
Table 2. GO: Biological Process and Co-expression analysis. The top 3,000 ranked DE expressed liver 
transcripts as determined by microarray analysis from 5.8 nM DEHP and 0.65 nM EE2 exposed adult male 
zebrafish relative to control fish were mapped to their human homologs using Ensembl homology. GO: 
Biological Process and co-expression terms and were enriched using ToppFun. The most significant terms for 
the DEHP and EE2 exposures, and those unique to DEHP (i.e. not present in in EE2 exposed) are presented.
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Zebra Entrez 
Gene ID Probe ID Gene Symbol Gene Name
Human 
Entrez 
ID
Human Gene 
Symbol
Log2 
ratio FC
FOXA2 and FOXA3 transcription factor networks
449677 A_15_P117834 cpt1b carnitine palmitoyltransferase 1B (muscle) 126129 CPT1C −5.80 −55.72
30262 A_15_P115731 ins preproinsulin 3630 INS −3.61 −12.21
317638 A_15_P105778 igfbp1a insulin-like growth factor binding protein 1a 3484 IGFBP1 −3.54 −11.63
30262 A_15_P110065 ins preproinsulin 3630 INS −3.26 −9.58
140815 A_15_P108996 cebpa CCAAT/enhancer binding protein (C/EBP), alpha 1050 CEBPA 3.20 9.19
573723 A_15_P101211 acadvl acyl-Coenzyme A dehydrogenase, very long chain 37 ACADVL −2.51 −5.70
445118 A_15_P107918 g6pca glucose-6-phosphatase a, catalytic 2538 G6PC −2.46 −5.50
322493 A_15_P107681 slc2a2 solute carrier family 2 (facilitated glucose transporter), member 2 6514 SLC2A2 2.20 4.59
445118 A_15_P107270 g6pca glucose-6-phosphatase a, catalytic” 2538 G6PC −2.06 −4.17
325881 A_15_P112672 f2 coagulation factor II (thrombin) 2147 F2 0.10 1.07
Fatty acid, triacylglycerol, and ketone body metabolism
436636 A_15_P111782 cd36 CD36 antigen 948 CD36 7.88 235.6
768196 A_15_P102657 me1 malic enzyme 1, NADP(+)-dependent, cytosolic 4199 ME1 6.01 64.45
386661 A_15_P112389 scd stearoyl-CoA desaturase (delta-9-desaturase) 79966 SCD5 5.33 40.22
768196 A_15_P107967 me1 malic enzyme 1, NADP(+)-dependent, cytosolic 4199 ME1 5.23 37.53
393984 A_15_P119395 aacs acetoacetyl-CoA synthetase 65985 AACS 5.00 32.00
317738 A_15_P108810 elovl6
ELOVL family member 6, 
elongation of long chain fatty acids 
(yeast)”
79071 ELOVL6 3.68 12.82
317738 A_15_P121489 elovl6
ELOVL family member 6, 
elongation of long chain fatty acids 
(yeast)
79071 ELOVL6 3.30 9.85
573723 A_15_P101211 acadvl acyl-Coenzyme A dehydrogenase, very long chain 37 ACADVL −2.51 −5.70
393622 A_15_P112797 acsl4a acyl-CoA synthetase long-chain family member 4a 2182 ACSL4 2.38 5.21
327417 A_15_P109573 hsd17b12a hydroxysteroid (17-beta) dehydrogenase 12a 51144 HSD17B12 2.20 4.59
Metabolic pathways
445818 A_15_P112409 cthl cystathionase (cystathionine gamma-lyase), like” 1491 CTH 6.60 97.01
447879 A_15_P114717 zgc:103408 zgc:103408 27231 NMRK2 6.44 86.82
768196 A_15_P102657 me1 malic enzyme 1, NADP(+)-dependent, cytosolic 4199 ME1 6.01 64.45
768196 A_15_P107967 me1 malic enzyme 1, NADP(+)-dependent, cytosolic 4199 ME1 5.23 37.53
436799 A_15_P115180 atp6v1f ATPase, H + transporting, V1 subunit F 9296 ATP6V1F 4.47 22.16
393799 A_15_P106842 pycr1 pyrroline-5-carboxylate reductase 1 5831 PYCR1 3.80 13.93
84039 A_15_P108167 bcmo1 beta-carotene 15,15’-monooxygenase 1 53630 BCO1 3.48 11.16
436919 A_15_P111364 ada adenosine deaminase 100 ADA 3.39 10.48
406651 A_15_P117346 ddc dopa decarboxylase 1644 DDC 3.31 9.92
406651 A_15_P111461 ddc dopa decarboxylase 1644 DDC 3.31 9.92
Metabolism of amino acids and derivatives
445818 A_15_P112409 cthl cystathionase (cystathionine gamma-lyase), like” 1491 CTH 6.60 97.01
393799 A_15_P106842 pycr1 pyrroline-5-carboxylate reductase 1 5831 PYCR1 3.80 13.93
406651 A_15_P117346 ddc dopa decarboxylase 1644 DDC 3.31 9.92
406651 A_15_P111461 ddc dopa decarboxylase 1644 DDC 3.31 9.92
572649 A_15_P108171 zgc:112179 zgc:112179 8424 BBOX 1 −2.81 −7.01
114426 A_15_P109191 odc1 ornithine decarboxylase 1 4953 ODC1 2.14 4.41
30665 A_15_P120879 psmb9a proteasome (prosome, macropain) subunit, beta type, 9a 5698 PSMB9 2.14 4.41
Continued
www.nature.com/scientificreports/
8SCieNtifiC RepoRTS |  (2018) 8:2118  | DOI:10.1038/s41598-018-20266-8
regulation of transcription and translation. Co-expression analysis revealed overlap with gene expression pat-
terns observed in apical endpoints such as liver cancer, and the up-regulation of genes in the mTORC1 pathway. 
An independent experiment exploited high throughput RNA-sequencing and this data supported these results, 
highlighting that DEHP exposure affected metabolic processes, particularly lipid metabolism. The DE mRNA 
signature unique to DEHP exposure was associated with GO terms related to gene expression, protein synthe-
sis, lipid/fatty acid metabolism and RNA metabolism. Co-expression analysis again revealed similarity to genes 
linked with adverse liver disease outcomes. Finally, we compared microarray and RNA-Seq analyses, based on the 
projection of zebrafish genes onto their human orthologs and subsequent analysis using the ToppGene Suite for 
gene list enrichment analysis and the following pathway annotations; BioSystems: Pathway Interaction Database, 
BioSystems: REACTOME and BioSystems: KEGG. This comparison uncovered five pathways: ‘FOXA2 and 
FOXA3 transcription factor networks’, ‘Metabolic pathways’, ‘metabolism of amino acids and derivatives’, ‘metab-
olism of lipids and lipoproteins’, and ‘fatty acid, triacylglycerol, and ketone body metabolism’ shared between the 
microarray and sequencing experiments.
The Benefits of Using Human Annotations in a Zebrafish Study. Presently the zebrafish genome 
is not as well characterized as the human genome and the level of functional annotation lags behind. However 
70% of protein-coding human genes are related to genes found in the zebrafish and 84% of genes known to be 
associated with human disease have a zebrafish counterpart34. It is therefore worthwhile to consider the human 
orthologs of the zebrafish genes in systems level analyses. As shown in Fig. 26 in terms of the ratio of human to 
zebrafish annotations, there are 5 times more non-inferred electronic and 2.2 times more functional annota-
tions in the human genome relative to the zebrafish (based on the Gene Ontology Consortium data April 2017). 
Utilizing GO terms for human orthologs provides a deeper systems level analysis than that obtained with zebraf-
ish genes. We achieved a greater number of enriched terms in mRNA signatures unique to EE2 using human 
orthologs: enrichment analysis of the zebrafish genes in GOrilla uncovered no significant results, whereas anal-
ysis of the corresponding human orthologs with ToppFun identified significant enriched terms. A limitation to 
this approach is the absence of specific genes, for example vitellogenins (VTGs) which do not have orthologs in 
humans21. However for a comparative analysis between zebrafish and humans, however, these limitations are 
outweighed by the benefits of improved annotations and the comprehensive systems analysis afforded.
Exposure to both DEHP and EE2 alter metabolic processes in the liver. Our data suggest that 
exposure to both EE2 and DEHP leads to the differential expression of genes involved in metabolic pathways 
representing molecular initiating events (MIEs). Since the liver is the primary site of metabolism within the body, 
the enrichment of metabolic pathways in both the DEHP and EE2 exposures was not unexpected. Among these 
common enrichment terms were changes to organic acid metabolism, in particular carboxylic acid metabolism35.
Zebra Entrez 
Gene ID Probe ID Gene Symbol Gene Name
Human 
Entrez 
ID
Human Gene 
Symbol
Log2 
ratio FC
100000775 A_15_P111686 glula glutamate-ammonia ligase (glutamine synthase) a 2752 GLUL −2.13 −4.38
321892 A_15_P118448 ckmt1 creatine kinase, mitochondrial 1” 1159 CKMT1B 1.93 3.81
399488 A_15_P101243
zgc:55813 zgc:55813 6520 SLC3A2 −1.87 −3.66
Metabolism of lipids and lipoproteins
436636 A_15_P111782 cd36 CD36 antigen 948 CD36 7.88 235.57
768196 A_15_P102657 me1 malic enzyme 1, NADP(+)-dependent, cytosolic 4199 ME1 6.01 64.45
386661 A_15_P112389 scd stearoyl-CoA desaturase (delta-9-desaturase) 79966 SCD5 5.33 40.22
768196 A_15_P107967 me1 malic enzyme 1, NADP(+)-dependent, cytosolic 4199 ME1 5.23 37.53
393984 A_15_P119395 aacs acetoacetyl-CoA synthetase 65985 AACS 5.00 32.00
768298 A_15_P117841 faah2b fatty acid amide hydrolase 2b 158584 FAAH2 3.83 14.22
317738 A_15_P108810 elovl6
ELOVL family member 6, 
elongation of long chain fatty acids 
(yeast)”
79071 ELOVL6 3.68 12.82
58128 A_15_P109314 fabp7a fatty acid binding protein 7, brain, a 2173 FABP7 3.56 11.79
58128 A_15_P102880 fabp7a fatty acid binding protein 7, brain, a 2173 FABP7 3.43 10.78
317738 A_15_P121489 elovl6
ELOVL family member 6, 
elongation of long chain fatty acids 
(yeast)
79071 ELOVL6 3.30 9.85
Table 3. DE genes from microarray analysis. in adult male zebrafish exposed to 5.8 nM DEHP relative to 
controls associated with enriched biological pathways (Metabolic Pathways; Fatty acid, triacylglycerol, and 
ketone body metabolism; FOXA2 and FOXA3 transcription factor networks; Metabolism of amino acids and 
derivatives; Metabolism of Lipids and Lipoproteins). Genes with the greatest fold change difference in DEHP 
exposed relative to control are presented. An expanded list of DE genes is presented in Supplementary Table S6.
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Co-expression results from ToppFun analysis identified overlaps between the DE mRNAs and the human 
orthologs of genes upregulated in the zebrafish crb (“crash and burn”) mutant, this mutation induces a 
loss-of-function of the gene bmyb, a transcription factor36. Loss of bmyb function can cause genome instability, 
and adult crb zebrafish heterozygotes have an increased cancer susceptibility36. Our results show that exposure 
to both DEHP and EE2 can mimic the effects of bmyb inactivation, suggesting a possible role for both molecules 
in carcinogenesis.
Unique effects of DEHP exposure indicate links with non-alcoholic fatty liver disease (NAFLD). 
The list of significant DE mRNAs overlaps with genes up-regulated in the liver of transgenic mice overexpressing 
sterol regulatory element binding transcription factors 1 and 2 (SREBF1 and SREBF2), and with low levels of 
SREBP cleavage-activating protein (SCAP) chaperone37. SREBF facilitates the development of NAFLD by increas-
ing the synthesis of fatty acids within hepatocytes38. SCAP is required for the activation of SREBPs, and knockout 
of SCAP in mice has been shown to reduce the rate of fatty acid synthesis in the liver39,40. Another xenoestro-
gen bisphenol A (BPA) was shown recently to produce hepatosteatosis in zebrafish and human hepatocytes by 
up-regulating the endocannabinoid system. Hepatosteatosis, was associated with an increase in the liver levels of 
the obesogenic endocannabinoids 2-arachidonoylglycerol and anandamide and a concomitant decrease in pal-
mitoylethanolamide41. Furthermore, we recently demonstrated that chronic BPA exposure impacts the hepatic 
epigenome in adult male zebrafish with altered gene expression signatures associated with non-alcoholic fatty 
liver disease (NAFLD) and cell cycle42. Similar results have been obtained in our laboratory with di-isononyl 
phthalate (DiNP) which upregulates orexigenic signals and causes hepatosteatosis together with deregulation of 
the peripheral endocannabinoid system (ECS) and lipid metabolism43.
Figure 3. Functional Analyses RNA-Seq data. (A) Overlap of the significant DE expressed liver transcripts 
(FDR < 0.4) from 5.8 nM DEHP and 0.65 nM EE2 exposed adult male zebrafish relative to control fish as 
determined by DESeq. 2. (B–D) Gene Ontology Biological Process analyses: Scatterplots shows the cluster 
representatives (i.e. terms remaining after the redundancy reduction) in a two dimensional space derived by 
applying multidimensional scaling to a matrix of the GO terms’ semantic similarities. Bubble color indicates 
the p-value (legend in upper right-hand corner); size indicates the frequency of the GO term in the underlying 
GOA database (bubbles of more general terms are larger). GO BP analysis of DE genes in (B) DEHP and (C) 
EE2 exposed livers. (D) GO BP analysis of DE genes unique to DEHP (not DE in EE2 exposed).
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Non-estrogenic effects of DEHP relate to changes in translation and membrane ruffling. When 
we analyzed DEHP’s global effects on the liver transcriptome, in parallel we assessed the effects of EE2. This 
allowed us to identify the estrogenic effects of DEHP, as well as separate non-estrogenic effects by considering DE 
mRNAs unique to DEHP exposure and therefore not regulated by EE2. Analysis of these unique mRNAs identi-
fied the non-estrogenic effects of DEHP exposure. GO analysis of zebrafish terms indicated that DEHP uniquely 
induced changes in translational initiation, a signature not observed with EE2 exposure. This is supported by data 
from both the microarray and RNA-Seq experiments.
Co-expression analysis of genes unique to DEHP exposure supported the connection between translational 
changes and DEHP exposure. We observed that genes DE in response to DEHP exposure overlapped with genes 
up-regulated in relation to the mTORC1 pathway; mTORC1 regulates protein synthesis by accepting growth 
factors to activate translation, consequently making it a major effector of cell growth and proliferation44,45. 
Dysregulation of mTORC1 is associated with the development of an increasing number of pathologies, including 
cancer46, obesity47,48, type 2 diabetes49,50, and NAFLD51,52. Along with Akt and S6K1, mTORC1 is a key component 
of the insulin signaling pathway, and has been identified as an enhancer of SREBP1c’s role as master transcription 
factor in lipid synthesis53; mTORC1 regulates SREBP by controlling the nuclear entry of a phosphatidic acid phos-
phatase called lipin 1, which mediates the effects of mTORC1 on SREBP target gene, SREBP promoter activity, 
and nuclear SREBP protein abundance52. Intriguingly, hyperactivity of mTORC1 in liver cells has been shown to 
protect against steatosis in mice51; deletion of Tsc1 in mouse liver cells, which codes hamartin (TSC1) of the tuber-
ous sclerosis complex (TSC) and controls the activity of mTORC154, specifically protected cells from high-fat diet 
induced, Akt-mediated steatosis through restriction of S6K1 independent of Akt suppression51.
We examined the most significantly deregulated mRNAs that are part of the mTORC1 pathway. PPP1R15A, 
LDLR, PNP, IFRD1, NUPR1, SSR1 and PNO1 were all downregulated in response to DEHP exposure. Protein 
Phosphatase 1 Regulatory Subunit (PPP1R15A) mRNA levels are increased following stressful growth arrest 
conditions55. The low density lipoprotein receptor (LDLR) gene encodes a cell surface protein involved in 
receptor-mediated endocytosis of specific ligands56. Purine Nucleoside Phosphorylase (PNP) encodes an 
enzyme which reversibly catalyzes the phosphorolysis of purine nucleosides57. Interferon Related Developmental 
Regulator 1 (IFRD1) is an immediate early gene that encodes a protein related to interferon-gamma, it can func-
tion as a transcriptional co-activator/repressor and control the growth and differentiation of specific cell types 
during embryonic development and tissue regeneration58. Nuclear Protein 1 Transcriptional Regulator (NUPR1) 
encodes a chromatin-binding protein that converts stress signals into a program of gene expression that empow-
ers cells with resistance to the stress induced by a change in their microenvironment59. The signal sequence 
receptor 1 (SSR1) is a glycosylated endoplasmic reticulum (ER) membrane receptor associated with protein trans-
location across the ER membrane60. ELOVL6, HMGCR, DHCR7, CYP51A1, HMGCS1, ME1, SQLE, SC5D, CTH, 
BCAT1, ACLY, ELOVL5, ACACA, HSPA5, HSPD1, IDH1 and ELOVL6 were all upregulated in response to DEHP 
exposure. Fatty Acid Elongase 6 (ELOVL6) uses malonyl-CoA as a 2-carbon donor in the first and rate-limiting 
step of fatty acid elongation61. 3-Hydroxy-3-Methylglutaryl-CoA Reductase (HMGCR) is the rate-limiting 
enzyme for cholesterol synthesis. 7-Dehydrocholesterol Reductase (DHCR7) encodes an enzyme that removes 
the C(7-8) double bond in the B ring of sterols and catalyzes the conversion of 7-dehydrocholesterol to choles-
terol. Cytochrome P450 Family 51 Subfamily A Member 1 (CYP51A1) encodes a member of the cytochrome 
GO Term Bonferroni q-value
DEHP Total
translation 6.09E-14
lipid metabolic process 1.05E-08
lipid biosynthetic process 7.01E-08
response to estrogen 2.94E-04
cytoplasmic translation 5.19E-04
response to hypoxia 1.24E-02
EE2 - Total
lipid biosynthetic process 8.58E-07
lipid metabolic process 2.58E-04
triglyceride metabolic process 2.05E-02
triglyceride-rich lipoprotein particle remodeling 6.13E-02
triglyceride catabolic process 9.03E-02
regulation of insulin-like growth factor receptor 
signaling pathway 1.03E-01
DEHP - Unique
translation 3.10E-16
fatty acid biosynthetic process 1.26E-15
protein metabolic process 1.29E-02
Table 4. RNA-Seq: GOrilla functional enrichment analysis. Significant DE expressed liver transcripts 
(FDR < 0.4) as determined by RNA-Seq from 5.8 nM DEHP and 0.65 nM EE2 exposed adult male zebrafish 
relative to control fish. The most significant terms for the DEHP and EE2 exposures, and those unique to DEHP 
(i.e. not present in in EE2 exposed) are presented.
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P450 superfamily and participates in the synthesis of cholesterol by catalyzing the removal of the 14alpha-methyl 
group from lanosterol. 3-Hydroxy-3-Methylglutaryl-CoA Synthase 1 (HMGCS1) is an enzyme that condenses 
acetyl-CoA with acetoacetyl-CoA to form HMG-CoA, which is the substrate for HMG-CoA reductase. Malic 
Enzyme 1 (ME1) encodes a cytosolic, NADP-dependent enzyme that generates NADPH for fatty acid biosyn-
thesis. The activity of this enzyme, the reversible oxidative decarboxylation of malate, links the glycolytic and 
citric acid cycles. Among its related pathways are Metabolism and Regulation of lipid metabolism by Peroxisome 
proliferator-activated receptor alpha (PPARalpha). Squalene Epoxidase (SQLE) catalyzes the first oxygena-
tion step in sterol biosynthesis. Sterol-C5-Desaturase (SC5D) encodes an enzyme of cholesterol biosynthesis. 
Branched Chain Amino Acid Transaminase 1 (BCAT1) encodes the cytosolic form of the enzyme branched-chain 
amino acid transaminase. ATP Citrate Lyase (ACLY) is the primary enzyme responsible for the synthesis of cyto-
solic acetyl-CoA in many tissues. ELOVL Fatty Acid Elongase (ELOVL5) encodes a multi-pass membrane protein 
that is localized in the endoplasmic reticulum and is involved in the elongation of long-chain polyunsaturated 
fatty acids. Acetyl-CoA Carboxylase Alpha (ACACA) is regulated by the phosphorylation/dephosphorylation of 
targeted serine residues and by allosteric transformation by citrate or palmitoyl-CoA. Heat Shock Protein Family 
A (Hsp70) Member (HSPA5) is localized in the lumen of the endoplasmic reticulum (ER), and is involved in the 
folding and assembly of proteins in the ER62. As this protein interacts with many ER proteins, it may play a key 
role in monitoring protein transport through the cell. Heat Shock Protein Family D (Hsp60) Member 1 (HSPD1) 
encodes a member of the chaperonin family.
GO Term Bonferroni q-value
GO: Biological Process
DEHP - Total
cotranslational protein targeting to membrane 1.01E-19
nuclear-transcribed mRNA catabolic process, nonsense-
mediated decay 1.79E-16
translational initiation 2.84E-15
peptide biosynthetic process 6.43E-14
EE2 - Total
small molecule biosynthetic process 2.27E-10
lipid biosynthetic process 3.87E-09
fatty acid metabolic process 7.42E-08
cholesterol metabolic process 9.28E-06
DEHP - Unique
protein targeting to ER 2.86E-19
translation 2.03E-16
rRNA processing 5.46E-14
ribonucleoprotein complex biogenesis 6.20E-11
EE2 - Unique
triglyceride metabolic process 5.09E-01
purine nucleoside monophosphate metabolic process 5.22E-01
response to dietary excess 5.47E-01
neutral lipid metabolic process 7.28E-01
Co-Expression
DEHP - Total
Genes up-regulated through activation of mTORC1 complex. 6.79E-14
Genes involved in cholesterol homeostasis. 6.58E-12
EE2 - Total
Genes down-regulated in hepatocellular carcinoma (HCC) 
compared to normal liver samples. 3.12E-05
Genes encoding proteins involved in metabolism of fatty acids. 4.65E-04
DEHP - Unique
Molecular timetable composed of 162 time-indicating genes
(182 probes) in the peripheral (liver) clock. 2.49E-12
Genes up-regulated in liver from mice transgenic for SREBF1 
or SREBF2 [GeneID = 6720, 6721] and down-regulated in 
mice lacking SCAP [GeneID = 22937].
4.78E-10
Table 5. RNA-Seq: GO: Biological Process and Co-expression analysis. Significant DE expressed liver 
transcripts (FDR < 0.4) as determined by RNA-Seq from 5.8 nM DEHP and 0.65 nM EE2 exposed adult 
male zebrafish relative to control fish were mapped to their human homologs using Ensembl homology. GO: 
Biological Process and co-expression terms and were enriched using ToppFun. The most significant terms for 
the DEHP and EE2 exposures, and those unique to DEHP (i.e. not present in in EE2 exposed) are presented. 
Expanded lists are found in Supplementary Tables S7–S10.
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We observed a reduction in the size of the liver in adult zebrafish in response to a seven day 100 nM DEHP 
exposure (Supplementary Figure S1). The mTOR signaling pathway senses and integrates a variety of environ-
mental cues to regulate organismal growth and homeostasis45. DEHP exposure in the nematode Caenorhabditis 
elegans was found to be acutely toxic, with decreases in body length and egg number per worm observed after 
24 h of DEHP exposure63. DEHP has also been shown to decrease serum estradiol levels and aromatase expres-
sion, prolong estrous cycles, and cause anovulation in animal and culture models and directly. It inhibits antral 
follicle growth via a mechanism that partially includes reduction in levels of estradiol production and decreased 
expression of cell cycle regulators64.
Other significant GO terms unique to DEHP exposure included ruffle assembly and organization - the forma-
tion of actin rich membrane protrusions typically used for cell motility65. In the context of the liver, ruffles form 
in response to insulin signaling. Mice with the fatty liver dystrophy (fld) mutation lose the ability to properly form 
membrane ruffles, the result of impairments in insulin-mediated cytoskeleton dynamics66. One of the hallmarks 
of this mutation is the formation of a fatty liver, similar to what is observed in NAFLD67. Furthermore, in muscle 
cells, defective actin remodeling is associated with the development of insulin resistance68; defined as the inability 
of cells to be regulated by insulin signaling, insulin resistance is associated with adverse outcomes such as type 2 
diabetes, cardiovascular disease, and chronic liver disease69–71. Recently, exposure to DEHP has been implicated 
with disruption of the insulin signaling pathway of both rats and the human cell line L-02 by activating PPARG, 
reducing the liver’s ability to maintain glucose homeostasis and contributing to insulin resistance4. The signifi-
cant enrichment of an insulin-mediated pathway – ruffle organization – supports the role of DEHP as a disrupter 
of insulin function, including the potential to inhibit insulin signaling in liver cells. Analysis of the signatures 
unique to DEHP exposure has identified changes related to translation and membrane ruffling; combined with 
our co-expression analysis, these perturbations support an association between DEHP exposure and NAFLD.
Comparison of microarray and RNA-Seq platforms. Both the microarray and RNA-Seq analyses of the 
transcriptome identified perturbations in gene expression. While RNA-Seq is a newer more reproducible technol-
ogy with less background noise, and a greater dynamic range to measure gene expression, DNA microarrays are 
Figure 4. Heatmaps of significantly DE liver mRNAs as determined by DESeq. 2. (FDR < 0.4) in adult 
male zebrafish exposed to 5.8 nM DEHP relative to controls. DE genes associated with enriched biological 
pathways (A) Metabolism of amino acids and derivatives, (B) Metabolic Pathways, (C) Metabolism of Lipids 
and Lipoproteins, (D) Fatty acid, triacylglycerol, and ketone body metabolism and (E) FOXA2 and FOXA3 
transcription factor networks are plotted. Red and blue boxes indicate relative over- and under-expression with 
respect to a reference which is calculated as the mid-point between the control and exposed groups.
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still commonly utilized due to their cost and ease30. In the context of our results, we were interested in comparing 
microarray and sequencing analyses from the two different experiments where zebrafish were exposed to 5.8 nM 
DEHP. In general, we found that the results of our sequencing analysis supported those of our microarray analy-
sis; many of the same GO and co-expression terms were enriched in both analyses, including genes up-regulated 
with the loss of bmyb and changes in translation initiation in response to exposure to DEHP.
In addition, the sequencing analysis uncovered GO terms that strengthen the connection between DEHP 
exposure and the development of adverse outcomes in the liver. For example, analysis of the microarray data 
derived signatures unique to DEHP exposure identified enrichments in membrane ruffling, a process regulated 
by insulin in liver cells72. Analysis of the RNA-Seq data determined that exposure to DEHP enriched the same set 
of genes associated with changes in regulation of SREBF1 and SREBF2. These transcription factors are significant 
in the development of liver pathologies and insulin resistance, and support previous studies associating exposure 
to DEHP with dysregulation of the insulin pathway4. Taken together, the combined genomic platforms identified 
molecular initiating and key events in the liver transcriptome that are conducive to the development of insulin 
resistance.
Bone morphogenic protein 2 (BMP2) and the epigenetic effects of DEHP exposure. Analysis of 
DEHP’s unique mRNA signature obtained from the microarray experiment identified an overlap with genes that 
were down-regulated in the uterus upon knockdown of bone morphogenic protein 2 (BMP2) (Supplementary 
Table S3). In the uterus, BMP signaling is necessary for embryonic development, and BMP2 in particular is 
critical for embryonic implantation by inducing decidualization73, a rapid remodeling of uterine endometrial 
stroma into epithelial decidual cells that is critical for the progress of implantation74. Knockout of BMP2 in mice 
renders mothers infertile due to lack of signaling to the stromal cells to begin decidualization73. Outside of the 
uterus, exposure to DEHP has been associated with decreased expression of BMPs, including BMP2, in dam 
mesenchymal stem cells75. DEHP mediates its adverse effects by interfering with signaling mechanisms involved 
in oocyte growth (VTG), maturation via the bone morphogenetic protein-15 (BMP15), luteinizing hormone 
receptor (LHR), membrane progesterone receptors (mPRs) and ovulation (cyclooxygenase (COX)−2 (ptgs2)), 
thereby deeply impairing ovarian functions76; female zebrafish exposed to environmentally relevant doses of 
DEHP exhibited a significant decrease in fecundity with diminished rates of ovulation and embryo production.
DEHP causes epigenetic effects impacting gene expression in the developing testis77. Alterations in DNA 
methylation patterns caused by maternal exposure have been indicated to play a key role in DEHP-mediated 
testicular toxicity. Maternal exposure to DEHP at 500 mg/kg/d induces testicular dysgenesis syndrome in fetuses 
and embryos78. DEHP exposure has also been shown to significantly inhibit gap-junctional intercellular commu-
nication, likely providing the initial stimulus that enables cell transformation, and facilitates development of these 
cells into tumors79. In utero DEHP exposure delays maturation of fetal Leydig cells, with reduced mineralocorti-
coid receptor (MR; NR3C2) expression in the adult Leydig cell80. Activation of MR induces androgen synthesis81, 
whereas its inhibition blocks testosterone synthesis in the Leydig cell82. Interestingly, it has been shown that DNA 
methylation and histone modification play a role in the regulation of BMP283,84. Taken together, these studies 
suggest that DEHP could regulate the expression of BMP2 via epigenetic modification.
Conclusion
The focus of this study was to examine the global effects of exposure to environmental levels of the plasticizer 
DEHP in the adult male zebrafish and uncover perturbations that represent MIEs that can potentially lead to 
adverse outcomes. Our results indicate that exposure to DEHP and EE2 leads to the expression of liver genes 
related to the mTORC1 complex, fatty acid metabolism and the development of non-alcoholic fatty liver disease. 
Analysis of only the DE genes associated with exposure to DEHP reveals potentially non-estrogenic perturbations 
in eukaryotic translation and insulin signaling after exposure. This data supports previous studies that implicate 
DEHP as increasing the risk of developing NAFLD.
Materials and Methods
Ethinylestradiol and (2-ethylhexyl) phthalate exposure studies in zebrafish. For both the 
microarray and RNA-Seq experiments adult male zebrafish (Danio rerio) were housed in aquaria that were indi-
vidually heated using a 100 W aquarium heater to maintain a temperature of 26–29 °C, and the light–dark cycle 
was 14:10 h. The water pH ranged from 7.0 to 7.6 throughout the duration of the experiment. Aeration and filtra-
tion were provided using sponge filters. Fish were fed two times a day with commercial flaked fish food (Tetra, 
Germany). Fish were acclimated for one week prior to commencing the experiments. Three tanks (80 l/tank) 
with 40 animals each were prepared for the different experimental groups, one containing water with 5.8 nM of 
(2-ethylhexyl) phthalate (DEHP), one tank containing water with 0.65 nM of ethinylestradiol 17-α (EE2), and 
one tank containing water and ethanol as negative exposure control. The levels of DEHP are considered “envi-
ronmentally relevant19,” and previous studies have determined that exposing model organisms to these concen-
trations is associated with altered effects on the transcriptome21,76,85,86. All chemicals were dissolved in ethanol 
and stock working solutions were prepared, from which the working experimental concentrations were prepared. 
The nominal exposures utilized a continuous flow-through system. Following a 21 day exposure the fish were 
sacrificed and sampled for liver tissue. Tissue samples were immediately frozen in liquid nitrogen and stored at 
−70 °C. For the liver mass experiments, animals were exposed to 100 nM of DEHP or EE2 for seven days, and the 
animals were sampled for liver tissue. All procedures involving zebrafish were performed in accordance with The 
University of California San Diego, Institutional Animal Care and Use Committee (IACUC) guidelines. All the 
experiments described above were approved by the IACUC and were performed in accordance with institutional 
guidelines and regulations.
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RNA Extraction. Isolation of total RNA from zebrafish liver samples was performed using TRIzol reagent 
(Invitrogen) and the extracted RNA were further purified using the RNeasy Mini kit (Qiagen, Valencia, CA). 
All RNA was subjected to on-column digestion of DNA during RNA purification from cells, to ensure highly 
pure RNA free from DNA contamination. The concentrations were determined by absorbance readings (OD) at 
260 nm using an ND-1000 (Nanodrop, Wilmington, DE). RNA was further assessed for integrity with the 6000 
Nano LabChip assay from Agilent, (Santa Clara, CA). Only RNA samples with a RIN score of >7.0 were used for 
genomic analyses. There were 18 samples in total (six EE2 exposed, six DEHP exposed, six control fish), selected 
for RNA extraction.
Microarray Analysis. Using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent), 100 ng of 
total RNA were converted into fluorescently labeled Cy3 cRNA. Unincorporated nucleotides of fluorescent targets 
were removed using RNeasy (Qiagen). Absorbance (OD) at 260 nm was used to quantify cRNA concentrations, 
and absorbance at 550 nm was used to measure Cy3 dye incorporation. Microarray hybridization was only carried 
out with cRNA that had an incorporation efficiency of 9 pmol/µg or greater.
We utilized the Agilent D. Rerio Oligo Microarray 4 × 44 K G2519F (015064), array design A-MEXP-1396 
(Santa Clara, CA). cRNA target hybridization to the zebrafish microarray was carried out in accordance with 
single color Agilent Hybridization protocols, and have been described previously25. Array data were collected 
using an Agilent Microarray Scanner and Feature Extraction Software (v10.5), and deposited in the ArrayExpress 
Database, accession number E-TABM-547. Though Agilent’s Feature Extraction Software (v10.5) provides high 
quality expression reports for microarrays, the data still needed to be normalized to remove background technical 
noise and other subtle biases caused by hybridization. For this experiment, statistical analysis of the microar-
ray experiment involved two steps: normalization and sorting of genes according to interest. All samples were 
normalized simultaneously using the multiple-loess technique87. Log ratios for each probe (technical replicates) 
were calculated separately, then averaged over the biological replicate microarrays. The data was sorted using the 
interest statistic, which reflects the understanding that the gene with a greater absolute fold change is potentially 
more interesting, (which we have described in greater detail previously)24–26. The design of the interest statistic 
was based on ideas borrowed from the software package Focus88.
RNA sequencing (RNA-Seq). To prepare RNA-Seq libraries using the TruSeq RNA Sample Prep Kit 
(Illumina, San Diego, CA), 100–200 ng of total RNA was used following the protocol described by the manufac-
turer. High throughput sequencing (HTS) was performed using an Illumina GAIIX with each sample sequenced 
to a minimum depth of ~2 million reads. A single end 50 cycle sequencing strategy was employed. Data were 
subjected to Illumina quality control (QC) procedures (>80% of the data yielded a Phred score of 30). RNA-Seq 
data has been submitted to the NCBI Gene Expression Omnibus, accession number GSE100367. Secondary 
analysis was carried out on an OnRamp Bioinformatics Genomics Research Platform (OnRamp Bioinformatics, 
San Diego, CA)30. OnRamp’s advanced Genomics Analysis Engine utilized an automated RNA-seq workflow 
to process the data89,90, including (1) data validation and quality control, (2) read alignment to the zebrafish 
genome (GRCz10) using TopHat291, which revealed >73% mapping, (3) generation of gene-level count data with 
HTSeq.92, and (4) differential expression analysis with DEseq. 293. Transcript count data from DESeq. 2 analysis 
of the samples were sorted according to their adjusted p-value (or q-value), which is the smallest false discovery 
rate (FDR) at which a transcript is called significant. FDR is the expected fraction of false positive tests among 
significant tests and was calculated using the Benjamini-Hochberg multiple testing adjustment procedure30,31,93,94.
Gene Ontology and Pathway Analyses. The Gene Ontology Enrichment Analysis and Visualization 
Tool (GOrilla) was used to search enriched GO terms associated with DEHP and EE2 exposures27,95. Data was 
further analyzed with the GO summarization tool REViGO96 which combines redundant terms into a single, 
representative term based on a simple clustering algorithm relying on semantic similarity measures. We exploited 
Ensembl homology to append a human gene ID to a given zebrafish gene ID, in order to permit systems anal-
ysis using the ‘Transcriptome, ontology, phenotype, proteome, and pharmacome annotations based gene list 
functional enrichment analysis’ (Toppfun) tool and the richer Gene Ontology content available for human 
compared to zebrafish6. ToppFun sources content from multiple databases, including KEGG, WikiPathways, 
and REACTOME97–99. To ensure that only the most relevant terms were selected, we applied Bonferroni FDR 
correction.
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